Summary. Discrete lesions in the medial or lateral subregion of the rostral caudate-putamen (CP) were induced by bilateral intracerebral injections of a low dose of quinolinic acid (30 nmol in 1 gl/per side) in rats. Quinolinic acid lesions in the lateral CP potently reversed haloperidol-induced catalepsy (0.5 mg/ kg,i.p.), while lesions in the medial CP were not effective. Spontaneous locomotor activity was not altered significantly after quinolinic acid lesions of either the medial or lateral CP. These results show that the lateral CP seems to be important for the expression of neuroleptic-induced catalepsy and thus further corroborate the concept of a functional heterogenity of the striatum.
Introduction
Systemic administration of dopamine (DA) D 1 or D 2 receptor-antagonists induce in rats catalepsy (0gren and Fuxe, 1988), i.e. a state of postural immobility (akinesia) and muscular rigidity. The available evidence suggests that catalepsy mainly originates from a blockade of D 1 or D 2 receptors in the caudate-putamen (CP) or a decreased presynaptic DA activity in this structure, since intrastriatal infusions of DA-antagonists (Elliott et al., 1990 a; Ossowska et al., 1990) , 6-hydroxydopamine-lesions of the mesostriatal DA system or reserpine treatment produced catalepsy (see Schmidt etal., 1992 for review).
The striatum receives not only DAergic projections from the mesencephalon, but also extensive and topographically arranged afferents from the cerebral cortex (Webster, 1961) using most probably glutamate as transmitter (Fonnum, 1984) . These glutamatergic afferents play an important role for the expression of catalepsy, since lesions of the corticostriatal pathway reduced neuroleptic-induced catalepsy (Scatton etal., 1982; Warenycia etal., 1987; Worms etal., 1985) . Furthermore, glutamate that derives from corticostriatal pathways and acts on the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors is a prerequisite for the cataleptogenic action of haloperidol, because infusion of the competitive NMDA-antagonist D-2-amino-5-phosphonopentanoic acid (AP-5) into the CP or frontal decortication reduced neuroleptic-induced catalepsy (Yoshida et al., 1991) . In addition, striatal infusion of NMDA restored haloperidol-induced catalepsy in frontally decorticated rats in this study.
It is likely that striatal output neurons bearing NMDA receptors mediate these anticataleptic effects, since striatal lesions with quinolinic acid (Schmidt and Bischoff, 1988; Calderon etal., 1988) potently antagonized neurolepticinduced catalepsy. Quinolinic acid is a selective agonist at the NMDA receptor and a potent neuroexcitotoxin which preferentially destroys spiny neurons using GABA and substance P or enkephalin as transmitter while sparing striatal afferents and interneurons (Beal etal., 1988) .
However, little is known in which subregion of the CP this effect was brought about. There is considerable anatomical, biochemical and behavioural evidence for a functional differentiation of the striatum (see Goldman-Rakic and Selemon, 1990 for review). Various studies showed that the more rostral part of the striatum is the subregion most sensitive to the cataleptogenic effects of neuroleptics (Ellenbroek etal., 1985; Klockgether et al., 1988; Ossowska et al., 1990) . This view was further confirmed by the finding that infusion of the competitive NMDA-antagonist AP-5 into the rostral part, but not into the intermediate part of the CP abolished neuroleptic-induced catalepsy (Yoshida etal., 1991) . On the other hand there is growing evidence that not only the anterio-posterior, but also the medio-lateral organization of the striatum is behaviourally relevant. Lesions in the medial part of the CP produced selective impairments in maze performance and discrimination learning (Wikmark et al., 1973; Divac et al., 1978; Pisa and Cyr, 1990; Hauber and Schmidt, 1989) whereas lesions in the lateral part of the CP induced motor deficits in various tasks (Sabol etal., 1985; Pisa, 1988; Pisa and Schranz, 1988; Pisa and Cyr, 1990) . The medial and lateral subregion of the CP mediate behavioural functions which are related to those mediated by the anatomically linked regions of the cortex. Thus it was proposed that there may exist different cortico-striatal functional loops which may mediate different aspects of behaviour (Alexander etal., 1986) . In the rat, the medial subregion of the CP receives prominent glutamatergic projections from the medial prefrontal cortex. This cortico-striatal loop has been implicated in processing cognitive, i.e. non-motor, complex functions. In contrast, the lateral subregion of the CP and the anatomically related sensorimotor cortical regions have been suggested to mediate motor functions (see Robbins and Brown, 1990 for review) .
In the present study, we tested this hypothesis with regard to neurolepticinduced catalepsy. We investigated the effects of lesions in the motor loop or cognitive loop on neuroleptic-induced catalepsy using quinolinic acid infusions in the respective subregions of the rostral CP. It has been already shown that quinolinic acid lesions counteract neuroleptic-induced catalepsy (see above). However, in these studies high doses of quinolinic acid were used and the resulting massive striatal damage thus prevented to detect the striatal subregion which may be relevant to this effect. Therefore, a low dose of quinolinic acid was used in this study to produce relatively circumscribed lesions. It was expected that the expression of catalepsy which is a motor phenomenon depends of the integrity of the motor loop. Thus discrete lesions in the relevant motor subregion in the CP should counteract neuroleptic-induced catalepsy, while lesions in the cognitive loop should not alter this response. We used lesion placements in the medial and lateral subregion of the rostral CP which are not exactly in the same anterio-posterior plane. According to anatomical studies the medial prefrontal cortex projects primarily to the most rostral parts of the medial CP, while the sensorimotor cortex mainly projects to a more caudal subregion of the lateral CP (Berendse et al., 1992; McGeorge and Faull, 1989) . Thus the placement for the medial lesion was more rostral than for the lateral lesion.
We report here that quinolinic acid lesions in the lateral CP, but not in the medial CP potently reversed haloperidol-induced catalepsy, while spontaneous motor activity measured in an open field was not altered significantly after lesions in these striatal subregions.
Materials and methods

Animals
Twenty-five male Sprague-Dawley rats (Interfauna, Tuttlingen, F.R.G.) weighing 220-250 g were used. They were housed in groups (5 per cage) and provided with 12 g standard laboratory chow per rat/day. Water was freely available. The animals were kept on a 12-h light-dark cycle (light 06.00-18.00). The temperature in the colony room was adjusted on 22 + 3 ~ Prior to this study, the animals were trained in a reaction time experiment (Hauber etal., 1991) . No drugs were administered during this test.
Surgery
Surgery was performed under sodium pentobarbital (Serva, Heidelberg, F.R.G.) anaesthesia (50 mg/kg, i.p.) combined with atropine sulfate (Serva, Heidelberg, F.R.G.) pretreatment (0.25 mg/kg, i.p.). Rats were placed in a Trent Wells stereotaxic instrument and quinolinic acid (Sigma, Deisenhofen, F.R.G.)(30 nmol in 1 gl 0.1 M phosphate buffer, pH 7.0) or vehicle (1 gl 0.1 M phosphate buffer, pH 7.0) was infused via a 26 gauge cannula at a constant rate over 10 min. The cannula was left in place for 2 rain after the infusion. Lesions in the medial or lateral subregion of the CP were made at the following placements according to the atlas of Paxinos and Watson (1986) : medial: AP: + 2.0, L2.0, V5.0; lateral: AP + 0.9, L3.5, V5.5.
Histology
At the end of the behavioural testing the animals were anaesthetized with sodium pentobarbital (50mg/kg, i.p.) and transcardially perfused with 0.9% saline followed by a 4% solution of phosphate buffered formalin (pH 7.4). Brains were removed, postfixed and thereafter stored in 30% sucrose solution. Coronal sections of 40 gm were cut in a cryostat (Reichert & Jung, F.R.G.) and stained with cresyl violet. The sections were examined by light microscopy for qualitative assessment of quinolinic acid-induced neuronal damage. The areas of neuronal loss and gliosis from different anterio-posterior planes revealed by cresyl violet staining were mapped on standardized brain sections from the atlas of Paxinos and Watson (1986) .
Procedure
Two weeks after the lesion spontaneous locomotor activity of the animals was assessed in an open field (69 x 69 cm) divided by lines in 9 squares of equal size. The open field box was opaque and illuminated by 4 red light bulbs (20 W); back ground noise was masked by a fan. Each animal was placed individually for 10 rain into the open field. Locomotor activity was monitored by video recording and evaluated by counting the number of line crossings during the observation period. The following day, the animals were tested for catalepsy induced by intraperitoneal injection of 0.5 mg/kg haloperidol (Janssen, Neuss, F.R.G.). Thirty and 60 rain after injection of haloperidol the degree of catalepsy was assessed in 3 tests performed in the following order (Scheel-Kriiger, 1983): 1.) Bar: both forelegs were placed on a horizontal bar (9 cm above the surface). 2.) Podium: one forleg was placed on a podium (3 cm high). 3.) Grid: an animal was clinged to a vertical wire grid. The latency from paw placement until complete removal of one paw from a support was measured (maximum 180 s) and termed here as descent latency.
Statistics
The data are presented as mean descent latencies and standard errors of the mean (SEM) for each test and group with infusions in either the medial CP (quinolonic acid, n--7; vehicle, n = 5) or lateral CP (quinolinic acid, n = 7; vehicle, n = 6). The data were subjected to a two-tailed Mann-Whitney U-test. Differences were considered to be significant if the p-value was less than 0.05.
Results
Spontaneous locomotor activity
The spontaneous locomotor activity of animals with quinolinic acid lesions of the medial CP was not significantly different from their controls (U = 15, p > 0.05). No significant differences were also found between animals with quinolinic acid lesions in the lateral CP and their controls (U = 12, p > 0.05), but the locomotor activity of laterally lesioned rats was enhanced (Fig. 1) .
Catalepsy
Quinolinate lesions of the medial CP induced a marginal reduction of the degree of catalepsy, since descent latencies were shorter than those of control animals in each test (Fig. 2) . These differences were not significant [grid: U (30 min) = 8.5, p > 0.05, U (60rain)= 12, p >0.05; podium: U (30min)= 9, U (60min) = 14, p > 0.05; bar: U (30rain) = 12.5, p > 0.05, U (60min) = 17, p > 0.05].
By contrast, lesions of the lateral CP induced a significant reduction of the descent latencies in each test [-grid (Fig. 3 ). Figure 4 shows the extent of the quinolinic acid-induced neuronal cell loss and gliosis in medial or lateral striatal areas. Quinolinic acid infusion produced a circumscribed area of neuronal cell loss (Fig. 5) . Within this area a moderate degree of gliosis was found. Ventricular alterations or striatal shrinkage were not observed. The size of the lesions was relatively homogeneous within each group of lesioned animals. In addition, the overlap between the extent of lesions in the medial and lateral CP was minimal. In control animals no signs of neurodegeneration were detected except gliosis along the cannula tack and at the cannula tip (not shown). and that the threshold dose of quinolinate producing striatal lesions of a consistent size is about 30nmol (Davies and Roberts, 1988) . Numerous studies have shown that striatal quinolinic acid injections induced a pronounced degeneration of spiny neurons containing GABA and substance P/enkephalin, whilst aspiny neurons were preserved (see Beal, 1992 for review). In addition, cholinergic neurons were spared at least at the dose used here (Davies and Roberts, 1988) . Thus quinolinic acid-induced behavioural effects observed in the present study are most probably due to the loss of striatal GABAergic projection neurons bearing NMDA receptors. The present study revealed that relatively small lesions of either the medial or lateral CP did not significantly affect spontaneous locomotor activity. This is accordance with a report of Sanberg et al. (1989) demonstrating that extensive lesions with quinolinic acid doses of 150-225 nmol are required to produce locomotor abnormalities (but see Emerich et al., 1991) .
Histology
Furthermore, we found that lateral striatal lesions induced a massive anticataleptic effect while medial lesions were not effective. At variance with these results are data from Calderon etal. (1988) showing that only striatal infusion of high doses (150-225 nmol) quinolinate dose-dependently abolished haloperidol-induced catalepsy while a lower dose (75 nmol) induced no overall significant decrease in the catalepsy response. Several reasons may contribute to these discrepancies: First, in the study of Calderon etal. (1988) a different lesion placement (coordinates with reference to bregma: AP + 1.3 mm; ML+ 2.5 mm, DV 5.2 mm from dura) and twice the dose of haloperidol was used, thus more extensive lesions were probably necessary to reduce the catalepic response. Second, intrastriatal quinolinic acid injection in doses of about 200 nmol induced ventricular enlargement, striatal atrophy (e.g. Emerich et al., 1991) and cerebral oedema in parts of the overlying cortical tissue as recently detected by in-vivo magnetic resonance imaging in rats (Sauer et al., 1992) which may interfere with the catalepsy response.
Thus the degree of the anti-cataleptic effect is not only dependent on the dose of quinolinic acid as shown by Calderon et al. (1988) , but is also critically dependent on the striatal area of the quinolinic acid lesion as shown by the present study. The latter finding is in accordance with the view of a functional heterogenity of the striatum. In the rat, the medial part of the CP receives prominent glutamatergic projections from the prefrontal cortex and this corticostriatal loop has been implicated in processing cognitive functions. In contrast, the lateral striatum and the anatomically related sensorimotor cortical regions have been suggested to mediate motor functions (see Introduction). The present results further corroborate this concept since we found a functional differentiation of the medial and lateral CP with regard to catalepsy: the lateral CP as a part of the motor loop is a prerequisite for the expression of haloperidol induced catalepsy. Striatal infusion of haloperidol induced hindlimb rigidity in rats (Ellenbroek et al., 1988) as detected by a paw test (Ellenbroek et al., 1987) . This effect could be mediated by haloperidols action within the lateral CP which includes limb representations in rats (Ebrahimi et al., 1992) . Thus a lesion in the lateral CP may counteract hindlimb rigidity and contribute to the anticataleptic effect observed in the present study.
The concept of functional cortico-striato-cortical loops further implicates that lesions in different parts of the same loop should have similar behavioural consequences. This was in fact confirmed in different paradigms. For instance, lesions within the medial prefrontal cortex or the medial striatum produced similiar impairments in maze leafing (Dunnett and Iversen, 1981; Simon and LeMoal, 1984; Wikmark et al., 1973) . The avaible catalepsy data further support a role of the motor loop for the expression of catalepsy: while extensive lesions of the frontal cortex reversed neuroleptic-induced catalepsy (Scatton et al., 1982; Warenycia etal., 1987; Worms etal., 1985; Yoshida etal., 1991) , lesions of the medial prefrontal cortex induced only a weak anti-cataleptic effect (Carter and Pycock, 1987) .
Furthermore, the present results may have implications for the striatal site of action of systemically administered NMDA-antagonists: dizocilpine, a potent NMDA-antagonist reversed neuroleptic-induced catalepsy (Schmidt and Bubser, 1989; Metha and Ticku, 1990; Elliott etal., 1990b) and NMDA given systemically in combination with haloperidol potentiated the cataleptogenic effects of haloperidol (Metha and Ticku, 1990) . From the present results one may conclude that within the CP the anti-cataleptic effects of systemically administered NMDA antagonists is mediated mainly through quinolinic acidsensitive projection neurons in the lateral CP.
